eHealth Inc
🔔 Watch stock
Stock Watch
Stock Watch will tell you what changes at eHealth Inc.
Later $1 a month per stock — signing up is free, and you'll be the first to know when it launches.
Price history
Chart
Interactive price chart (TradingView).
52-week range: 0.8527 $ to 5.70 $ · Last price: 0.889 $ (As of: September 18, 2026)
Key figures
Key figures at a glance
Every figure we hold for this stock, grouped by topic. The question mark next to a label explains what the number means.
Basics
Performance
Technical Indicators
Calculated from the price history · as of 09/18/2026
Valuation
Profitability
Balance Sheet & Safety
Growth
Dividend
This stock currently pays no dividend.
Quality & Screener
Comparison
Industry comparison
The stock alongside the largest companies in the same group. The median row is the middle value of the companies shown above — not of the whole industry.
Industry: Insurance Brokers
| Company | Market cap ($B) | P/E | EV/EBITDA | Gross Margin % | EBIT Margin % | Sales Growth (Year) % | Perf. 1Y % |
|---|---|---|---|---|---|---|---|
| eHealth Inc EHTH | 0.0 | – | 0.9 | 100.0 | – | 4.1 | -77.9 |
| Marsh & McLennan Companies, Inc. MRSH | 84.9 | 22.6 | 14.6 | 44.0 | 24.3 | 10.3 | -9.0 |
| Aon PLC AON | 63.1 | 17.1 | 11.7 | 48.2 | 35.8 | 9.5 | -15.4 |
| Arthur J Gallagher & Co AJG | 61.5 | 40.9 | 18.7 | 43.2 | 28.4 | 20.7 | -18.3 |
| Willis Towers Watson PLC WTW | 29.3 | 18.7 | 13.1 | 42.5 | 20.5 | -2.2 | -5.3 |
| Brown & Brown Inc BRO | 22.0 | 22.8 | 12.1 | 56.3 | 47.2 | 26.6 | -28.7 |
| Erie Indemnity Company ERIE | 12.5 | 21.7 | 0.0 | 17.9 | 19.1 | 7.2 | -23.6 |
| Accelerant Holdings ARX | 4.3 | – | 0.0 | 65.1 | -2.2 | 47.2 | 15.0 |
| Neptune Insurance Holdings Inc. NP | 4.1 | 141.8 | 58.6 | 52.7 | 47.5 | 33.7 | – |
| Median of companies shown | 22.0 | 22.6 | 12.1 | 48.2 | 26.4 | 10.3 | -16.9 |
Based on the most recently reported figures. Only stocks from the same trading venue are lined up, so the market caps are counted in one currency. Compare in a chart →
Fiscal years
Annual Figures
Fiscal years from the audited annual reports, oldest first. EBIT is the operating profit before interest and taxes; total assets are everything the company owns.
Revenue, operating income and net income per fiscal year $M
Revenue Operating income Net income
| Fiscal Year | Revenue ($M) | EBIT ($M) | Net Income ($M) | EPS ($) | Operating Cash Flow ($M) | Equity ($M) | Total Assets ($M) |
|---|---|---|---|---|---|---|---|
| 2016 | 193 | 3 | 0 | 0.02 | 4 | 78 | 109 |
| 2017 | 191 | -9 | 25 | 1.33 | -16 | 287 | 359 |
| 2018 | 251 | 3 | 0 | 0.01 | -3 | 303 | 439 |
| 2019 | 506 | 81 | 67 | 2.73 | -71 | 527 | 742 |
| 2020 | 583 | 53 | 45 | 1.68 | -108 | 838 | 1,040 |
| 2021 | 538 | -126 | -104 | -3.90 | -163 | 750 | 1,149 |
| 2022 | 405 | -103 | -89 | -3.24 | -27 | 651 | 1,113 |
| 2023 | 453 | -29 | -28 | -1.01 | -7 | 904 | 1,113 |
| 2024 | 532 | 24 | 10 | 0.34 | -18 | 588 | 1,155 |
| 2025 | 554 | 69 | 40 | 1.31 | -25 | 974 | 1,262 |
Quarters
Quarterly Figures
Each bar is one quarter, the last one is the most recent. Use the switch to step through the individual figures.
Revenue & Profit
Cash Flow
Balance Sheet
Margins
Per Share
Click the chart or tab into it, then use ← and → to step through the periods.
None of the selected stocks reports this metric. Pick another metric or switch between annual and quarterly.
· Total · per year
These companies report in different currencies — switch on “Indexed” or pick a margin for a fair comparison.
The figures could not be loaded right now.
Source: fundamental data
| Quarter | EPS (Earnings Per Share) | EPS YoY (%) | Sales ($M) | Sales YoY (%) | Net Margin (%) | OCF ($M) | FCF ($M) |
|---|---|---|---|---|---|---|---|
| 2024: Q4 | 3.07 | 86.80 | 315 | 27.30 | 30.90 | -28 | -31 |
| 2025: Q1 | 0.06 | – | 113 | 21.70 | 1.70 | 77 | 77 |
| 2025: Q2 | -0.98 | – | 61 | -7.70 | -28.60 | -41 | -47 |
| 2025: Q3 | -1.46 | – | 54 | -7.80 | -58.80 | -25 | -29 |
| 2025: Q4 | 2.75 | -10.60 | 326 | 3.50 | 26.70 | -35 | -35 |
| 2026: Q1 | -0.15 | -341.70 | 88 | -22.20 | -5.40 | 36 | 36 |
| 2026: Q2 | -1.18 | -20.40 | 34 | -44.70 | -70.20 | -5 | -6 |
What Do These Terms Mean?
- EPS (Earnings Per Share):
- Quarterly profit divided by the total share count — how much of the profit works out to a single share.
- YoY (Year over Year):
- Change versus the same quarter a year ago — this is how you compare without seasonal distortion (e.g. the holiday shopping season).
- Sales:
- All revenue for the quarter, before any costs are deducted — the top line of the income statement.
- Net Margin:
- What percentage of sales is left over as profit in the end. Negative means the company is posting a loss.
- OCF (Operating Cash Flow):
- The cash that actually flows into the till from the core business during the quarter — harder to dress up than book profit.
- FCF (Free Cash Flow):
- Operating cash flow minus capital expenditures — the money that's genuinely free to use, say for paying down debt, buybacks, or dividends.
Screening
Appears in These Scanners
This stock currently matches 8 of our scanner strategies — each hit links to the scanner.
Momentum & Trend
Risk & Weakness
- Below the 50- & 200-SMA
- RS Weakness (≤10)
- Stage 4 (Downtrend)
- Stan Weinstein: Stage 4
- Stan Weinstein: Stage 4B-
- Weakness Cluster
Value & GARP
Only genuine hits from verified scanners count; pure ranking metrics (P/E, P/S, and similar, which just sort the whole universe) don't count as a hit. Scanners marked in red are red-flag signals (risk/short scanners) — appearing there is not a seal of approval. View all scanners
Outlook
Analysts & Price Target
Combined picture of the price targets and recommendations of every analyst covering the stock. Price targets are expectations for the next 12 months, not promises — and they often follow the price rather than predict it.
Distribution of Recommendations
Estimates by Fiscal Year
| Fiscal Year | EPS Estimate ($) | EPS Range ($) | Revenue Estimate ($M) | Expected Growth | Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | -1.27 | -1.32 – -1.24 | 422 | 3,432.3% | 3 |
| 12/31/2027 | -0.98 | -1.25 – -0.55 | 435 | -10.9% | 3 |
Average of the analyst estimates for the coming fiscal years. The range shows how far the most optimistic and the most cautious estimate sit apart — the wider it is, the less certain the expectation.
Valuation
What is priced in?
Free cash flow over the past twelve months is negative, which rules out a serious reverse calculation. Any growth rate only makes a negative cash flow more negative; no present value comes out of it. What the price reflects here is therefore not a stream of cash flows, but the expectation that there will be one at all.
A simplified model calculation — not a forecast and not a recommendation.
AI classification
AI Rating
eHealth setzt KI nachweislich operativ ein: KI ist in mehrere Komponenten der telefonischen Vermittlungsplattform integriert (KI-Screener zur Anrufer-Vorqualifizierung, KI-Voice-Agents für Aufnahme, Eignungsprüfung und Pflichthinweise, ein eigenes AI Center of Excellence, ein Chief Digital & AI Officer), und der Geschäftsbericht schreibt dem skalierten KI-Screener konkrete Effizienzgewinne und kürzere Wartezeiten zu. KI ist keine Umsatzquelle (kein KI-Produktverkauf). Bedroht-Prüfung dokumentiert: Die Risk Factors nennen KI-getriebene generative Suche als mögliches Risiko für die Kundengewinnung über SEO/Paid Search sowie »AI automation and search aggregation« im Wettbewerbsumfeld — beides konditional formuliert und auf den Marketing-Kanal bezogen, keine konkrete Verdrängung des Maklergeschäfts selbst; nach Vorrang-Regel daher »nutzt«.
View the full file — quotes, sources, reviewed filings
„Additionally, we have integrated artificial intelligence ("AI") across several components of our telephonic enrollment platform, enabling us to utilize AI to streamline the health insurance selection process and in many cases reduce wait time for consumers."
Darüber hinaus haben wir künstliche Intelligenz („KI“) in mehrere Komponenten unserer telefonischen Vermittlungsplattform integriert, sodass wir KI nutzen können, um den Auswahlprozess für Krankenversicherungen zu verschlanken und die Wartezeit für Verbraucher in vielen Fällen zu verkürzen.
10-K · 2026-02-26 · View SEC filing
„We scaled our Artificial Intelligence ("AI") screener during this past AEP, which resulted in increased efficiencies to our model while reducing call wait times."
Wir haben unseren Künstliche-Intelligenz-Screener („KI“-Screener) in der vergangenen jährlichen Wechselperiode (AEP) skaliert, was zu höherer Effizienz unseres Modells bei gleichzeitig kürzeren Anruf-Wartezeiten führte.
10-K · 2026-02-26 · View SEC filing
„We have begun utilizing our AI Center of Excellence to help guide and prioritize our AI and technology initiatives and have started implementing AI-based voice, non-licensed agents to help streamline the health insurance selection process. These AI-based voice agents initiate the customer intake process, gather personal information, check initial eligibility and communicate necessary disclosures."
Wir haben begonnen, unser AI Center of Excellence zu nutzen, um unsere KI- und Technologie-Initiativen zu steuern und zu priorisieren, und setzen erste KI-basierte Sprach-Agenten ohne Maklerlizenz ein, die den Auswahlprozess für Krankenversicherungen verschlanken. Diese KI-Sprach-Agenten starten die Kundenaufnahme, erfassen persönliche Daten, prüfen die grundsätzliche Anspruchsberechtigung und übermitteln vorgeschriebene Hinweise.
10-K · 2026-02-26 · View SEC filing
„As AI platforms generate results based on predictive models rather than traditional keyword search, our ability to reach consumers through established search-engine optimization, paid search, and other digital marketing channels may be adversely impacted."
Da KI-Plattformen Ergebnisse auf Basis von Vorhersagemodellen statt klassischer Stichwortsuche erzeugen, könnte unsere Fähigkeit beeinträchtigt werden, Verbraucher über etablierte Suchmaschinenoptimierung, bezahlte Suche und andere digitale Marketingkanäle zu erreichen.
10-K · 2026-02-26 · View SEC filing
Filings Reviewed: 10-Q 2026-05-07 · 10-Q 2025-11-06 · 10-Q 2025-08-07 · 10-Q 2025-05-07 · 10-K 2026-02-26 · 10-K 2025-02-27
Rated on July 10, 2026 · How the Rating Is Built
Growth
Growth Score
Ten checks against the annual reports — each one passed counts a point.
- Revenue grows by more than 15% a year over three years 11.0%
- More than 10% revenue growth is expected for the coming year 4.2%
- Share count grows by less than 3% a year 3.7%
- Revenue growth plus cash-flow margin add up to at least 40 ("Rule of 40") -3.3%
- Gross margin at 40% or higher and without meaningful erosion 97.5%
- Goodwill from acquisitions does not grow faster than revenue 0.0%
- Net debt below twice EBITDA 0.7 x EBITDA
- Operating cash flow covers the profits of the last three years -72 m
- Return on capital at 15% or higher, or up versus two years ago 5.9%
- Insiders hold at least 10% or are net buyers 7.6%
A criterion without figures counts neither as passed nor as failed; a score is only produced from 7 judgeable criteria upwards. Source: fundamental data. All ten criteria in detail
Quality check
AAQS
3/10The AAQS (AlleAktien Quality Score) checks 10 quality criteria on growth, profitability, and balance-sheet strength — per the methodology developed and published by AlleAktien, calculated by us from our own fundamental data. A stock counts as a quality stock from 9 out of 10 points. Where a company has a shorter listing history, we calculate over the fiscal years available (at least five).
- Sales growth 10Y > 5% 12.4%
- Exp. sales growth 3Y > 5% -11.4%
- EBIT growth 10Y > 5% 42.5%
- Exp. EBIT growth 3Y > 5% -11.4%
- Net debt < 4x EBIT 0.8x
- EBIT positive, 10Y straight 6
- Max. EBIT decline < 50% 100.0%
- Return on equity > 15% 4.2%
- ROCE > 15% 5.9%
- Expected return > 10% -140.1%
View stocks with the full AAQS score · Read the methodology at AlleAktien
Source: fundamental data
Insiders
Insider Transactions
Reportable transactions by officers and major shareholders from SEC Form 4 filings. "Other" includes things like stock grants and option exercises without a buy/sell character.
| Date | Person | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 10, 2026 | Barbeau Michelle Marie | Chief Revenue Officer | Other | 4,312 | 0.92 | 3,967 |
| Sep 10, 2026 | Dolan John Joseph | Chief Financial Officer | Other | 5,859 | 0.92 | 5,390 |
| Sep 1, 2026 | Barbeau Michelle Marie | Chief Revenue Officer | Other | 70,000 | 0.00 | – |
| Sep 1, 2026 | Galimi Gavin G. | SVP, General Counsel & Secr. | Other | 60,000 | 0.00 | – |
| Sep 1, 2026 | Dolan John Joseph | Chief Financial Officer | Other | 70,000 | 0.00 | – |
| Sep 1, 2026 | Soistman Francis S Jr | Director | Sell | 37,297 | 1.05 | 39,277 |
| Aug 31, 2026 | Soistman Francis S Jr | Director | Sell | 37,296 | 1.14 | 42,432 |
| Aug 4, 2026 | Duke Derrick A | Chief Executive Officer | Other | 24,350 | 1.42 | 34,577 |
| Jul 10, 2026 | Barbeau Michelle Marie | Chief Revenue Officer | Other | 323 | 1.62 | 523 |
| Jul 10, 2026 | Galimi Gavin G. | SVP, General Counsel & Secr. | Other | 841 | 1.62 | 1,362 |
The company
About the Company
eHealth, Inc. betreibt einen Krankenversicherungsmarktplatz, der in den USA Lösungen für Verbraucherengagement, Aufklärung und Krankenversicherungsabschluss bietet.
- Employees
- 1,665
- Headquarters
- Indianapolis, IN
- Address
- 9190 Priority Way West Drive, 46240 Indianapolis, United States
- Phone
- 737 248 2340
- Website
- ehealthinsurance.com
- IPO Date
- 10/13/2006
- ISIN
- US28238P1093
Management
| Name | Title | Birth Year |
|---|---|---|
| Derrick Anthony Duke C.F.A. | CEO & Director | 1967 |
| John Joseph Dolan | Senior VP & CFO | 1969 |
| Michelle M. Barbeau | Senior VP & Chief Revenue Officer | 1978 |
| Kate Sidorovich CFA | Senior Vice President of Investor Relations & Corporate Development | – |
| Gavin Guy Galimi | Senior VP, General Counsel & Corporate Secretary | 1973 |
| Lara Sasken | Senior VP & Chief Communications Officer | – |
| Bob Rees | Senior VP and Chief Sales & Carrier Officer | – |
| Jana Brown | Senior VP & Chief Human Resources Officer | – |
| Ketan Babaria | Senior VP, Chief Digital & AI Officer | – |
| Eli Newbrun-Mintz | Senior Investor Relations Manager | – |
Executives per the latest required filings; titles kept in their original language. Source: fundamental data.
Filings
Company Filings (8-K)
An 8-K is the filing a US company must use to disclose material events immediately — takeovers, changes at the top, major contracts or payment troubles, for instance. The links open the original document at the US Securities and Exchange Commission (SEC).
- 08/04/2026 eHealth, Inc. (EHTH): Results of Operations and Financial Condition; Financial Statements and Exhibits SEC ↗
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.